|
||||||||||||||||||||||||||
| SEC Info℠ | | | Home | | | Search | | | My Interests | | | Help | | | Sign In | | | Please Sign In | |||||||
|
||||||||||||||||||||||||||
¶ – Release Delayed to: 7/22/14 ·As Of Filer Filing For·On·As Docs:Size Issuer Agent 4/16/14 Tekla Healthcare Investors N-2¶ 15:2.0M Merrill Corp-MD/FA H&Q Healthcare Investors |
Document/Exhibit Description Pages Size
1: N-2 Registration Statement by a Closed-End Investment HTML 900K
Company
15: COVER ¶ Comment-Response or Cover Letter to the SEC HTML 10K
2: EX-99.A(III) Miscellaneous Exhibit HTML 17K
3: EX-99.A(IV) Miscellaneous Exhibit HTML 17K
7: EX-99.A(IX) Miscellaneous Exhibit HTML 17K
4: EX-99.A(V) Miscellaneous Exhibit HTML 17K
5: EX-99.A(VI) Miscellaneous Exhibit HTML 17K
6: EX-99.A(VIII) Miscellaneous Exhibit HTML 17K
8: EX-99.G Miscellaneous Exhibit HTML 45K
9: EX-99.J Miscellaneous Exhibit HTML 127K
10: EX-99.K(I) Miscellaneous Exhibit HTML 66K
11: EX-99.K(II) Miscellaneous Exhibit HTML 166K
12: EX-99.N(I) Miscellaneous Exhibit HTML 9K
13: EX-99.N(II) Miscellaneous Exhibit HTML 48K
14: EX-99.R Miscellaneous Exhibit HTML 57K
|
|
One International Place, 40th Floor 100 Oliver Street +1 617 728 7100 Main +1 617 426 6567 Fax |
|
|
|
|
|
+1 617 728 7161 Direct +1 617 275 8392 Fax |
VIA EDGAR
Securities and Exchange Commission
100 F. Street, N.E.
Washington, DC 20549
Re: H&Q Healthcare Investors (the “Fund”)
Registration Statement on Form N-2, File No. 811-04889
Ladies and Gentlemen,
On behalf of the Fund, transmitted herewith is a copy of the Fund’s Registration Statement on Form N-2, including exhibits, for filing under the Securities Act of 1933, as amended, and under the Investment Company Act of 1940, as amended (the “Registration Statement”).
This filing is for the registration and issuance of the Fund’s shares of beneficial interest, par value $0.01 per share (the “Shares”), pursuant to the exercise of rights to purchase the Shares to be distributed to the shareholders of the Fund in accordance with the Registration Statement (the “Offer”). The approximate date of the proposed public offering will be as soon as practicable after the effective date of the Registration Statement.
If you have any questions relating to this filing, please do not hesitate to contact me at 617.728.7161.
|
Sincerely, |
|
|
|
|
|
| |
|
|
|
|
|
| This ‘N-2’ Filing | Date | Other Filings | ||
|---|---|---|---|---|
 | ||||
| Filed on: | 4/16/14 | None on these Dates | ||
| List all Filings | ||||
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 9/27/23 Tekla Healthcare Investors POS EX 9/27/23 2:153K Toppan Merrill/FA 7/29/22 Tekla Healthcare Investors POS EX 7/29/22 2:63K Toppan Merrill/FA 7/01/22 Tekla Healthcare Investors POS EX 7/01/22 3:65K Toppan Merrill/FA 12/22/21 Tekla Healthcare Investors POS EX 12/22/21 3:66K Toppan Merrill/FA 7/02/21 Tekla Healthcare Investors POS EX 7/02/21 2:59K Toppan Merrill/FA 1/05/21 Tekla Healthcare Investors POS EX 1/05/21 2:152K Toppan Merrill/FA 9/10/20 Tekla Healthcare Investors POS EX 9/10/20 3:65K Toppan Merrill/FA |
